Location History:
- Cambridge, MA (US) (2016 - 2021)
- Belmont, MA (US) (2020 - 2023)
- Seattle, WA (US) (2021 - 2024)
Company Filing History:
7 out of 66 
3 out of 30 
2 out of 559 
Years Active: 2016-2025
Title: Inspiring Innovation: The Contributions of Csaba Pazmany
Introduction
Csaba Pazmany, an accomplished inventor based in Cambridge, MA, is recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of nine patents, he has demonstrated a relentless pursuit of innovation, particularly in the development of targeted therapies for cancer treatment.
Latest Patents
Among his latest inventions, Csaba has patented groundbreaking technologies related to antibodies and chimeric antigen receptors (CARs). His patent on "Antibodies and chimeric antigen receptors specific for ROR1" includes ROR1 binding molecules that encompass anti-ROR1 antibodies and fragments such as variable heavy chain regions. These innovations play a crucial role in enhancing adoptive cell therapy, providing genetically engineered cells that express chimeric receptors.
Additionally, he has developed another patent titled "Antibodies and chimeric antigen receptors specific for CD19," which includes CD19 binding molecules such as anti-CD19 antibodies and chimeric receptors. This work focuses on creating human antibodies that exhibit competitive binding properties, demonstrating similar functionalities to existing reference antibodies, thereby intensifying the impact of cell therapy approaches.
Career Highlights
Csaba Pazmany has had a notable career, working with prestigious companies such as Juno Therapeutics GmbH and X-Body, Inc. His expertise in biotechnology and dedication to advancing therapies have positioned him as a key innovator in the field.
Collaborations
Collaboration has been a cornerstone of Csaba's success. He has worked alongside talented professionals such as Yan Chen and Steven M. Shamah, contributing to a vibrant exchange of ideas and fostering an environment conducive to groundbreaking innovations.
Conclusion
In summary, Csaba Pazmany's contributions to biotechnology through his inventive patents have significant implications for cancer treatment and therapy. With a commitment to innovation and an impactful career trajectory, he continues to inspire future generations of inventors and researchers alike.